Drug intelligence / Profile preview

Amaranth

Development stage
Unknown
Lead developer
Amaranth Medica
Administration
Oral
01

Overview

Amaranth refers to the grain or seed derived from the *Amaranthus* plant genus, including species such as *Amaranthus tricolor L.* and *Amaranthus hypochondriacus*. It is a highly nutritious food source, rich in essential micronutrients like iron, zinc, calcium, vitamin E, and vitamin D, as well as macronutrients such as protein, dietary fiber, and beneficial monounsaturated and polyunsaturated fatty acids, including squalene. Amaranth is utilized as a dietary supplement and food ingredient to address nutritional deficiencies, particularly iron deficiency anemia and zinc deficiency, especially in vulnerable populations like children and pregnant women. Beyond its fundamental nutritional value, amaranth exhibits potential anti-inflammatory and antioxidant properties, attributed to its phenolic acids and fatty acids. It is also being investigated for its role in modulating insulin resistance and reducing oxidative stress, making it a subject of interest in managing conditions such as overweight and obesity. Furthermore, starch extracted from *Amaranthus hypochondriacus* seeds has been explored for its biopolymeric stabilization properties in advanced applications like bioimaging and photodynamic therapy.

Other names
Red AmaranthGrain AmaranthPigweedAmaranthus tricolor L.Amaranthus hypochondriacus
02

Targets

ACE (Angiotensin Converting Enzyme)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on Amaranth.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amaranth.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call